July 31, 2019 / 6:20 AM / 3 months ago

Indivior posts 14% rise in quarterly profit

July 31 (Reuters) - Drugmaker Indivior Plc reported a 14% rise in quarterly profit on Wednesday, as its best-selling opioid addiction drug Suboxone lost market share to generic rivals at a slower pace, than the company’s previous modelling had expected.

The maker of drugs that treat opioid addiction posted here a pretax profit of $89 million in the second quarter ended June 30, from $78 million a year earlier. (Reporting by Justin George Varghese in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below